ArticleProceedings of the National Academy of Sciences of the United States of America2018

Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protection.

Mark R SchleissPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.